CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 154 enrolled
Drug / intervention
Acetaminophen +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03020966
NCT03020966Phase 4Completed
CompareCT.gov

IV vs. Oral Acetaminophen as a Component of Multimodal Analgesia After Total Hip Arthroplasty: a Randomized, Blinded Trial

Hospital for Special Surgery, New York·interventional·Posted Jan 13, 2017·Updated Aug 10, 2021

In Brief

A Phase 4 clinical trial evaluating Acetaminophen for Pain, Postoperative and Opioid Use. Completed, enrolled 154 participants across 1 site.

Detailed Summary

The purpose of this study is to determine how well two different methods of administrating Tylenol reduce pain and improve patient satisfaction after total hip replacement (THR) surgery. The methods of administration are orally, via a pill that is to be swallowed, and intravenously. Our aim is to determine whether oral or intravenous administration of Tylenol will reduce opioid consumption and opioid-related side effects after THR.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain, Postoperative, Opioid Use
CountriesUnited States
CollaboratorsMallinckrodt

Timeline

Phase 4CompletedFinished
2017201820192020202120222023202420252026
First PostedJan 13, 2017
Enrollment StartFeb 16, 2017
Primary CompletionJun 16, 2019
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 9.5 years ago

Interventions

Acetaminophendrug

Oral acetaminophen, intravenous placebo

Acetaminophendrug

Intravenous acetaminophen, oral placebo